Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
J Pediatr 138:880887
Heres a breakdown of what happens as patients start using GLP-1 medications
November 2025: FDA approved expanded Zepbound (tirzepatide) indication for moderate-to-severe obstructive sleep apnea in adults with obesity, following SURMOUNT-OSA trial data showing 62.8% reduction in apnea-hypopnea index the first drug approval for sleep apnea treatment
2 School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
US$ 28.11
US$ 27.79
US$ 29.66
US$ 27.87
US$ 26.76
US$ 29.17
US$ 21.44
US$ 29.08
US$ 23.46
US$ 26.71
US$ 24.08
US$ 26.29
